Boswellic Acids: A Natural Compound with Expanding Therapeutic Horizons

Jyoti Kumari; M.P. Chopra

doi:10.52711/0974-360X.2026.00270

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Boswellic Acids: A Natural Compound with Expanding Therapeutic Horizons

Author(s): Jyoti Kumari, M.P. Chopra

Email(s): mpchopra054@gmail.com

DOI: 10.52711/0974-360X.2026.00270

Address: Jyoti Kumari, M.P. Chopra*
Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.
*Corresponding Author

Published In: Volume - 19, Issue - 4, Year - 2026

View HTML

Purchase PDF

ABSTRACT:
BSTRACT: Boswellic acids, derived from the resin of Boswellia species, exhibit diverse pharmacological effects and potential therapeutic applications for various illnesses. Traditionally utilized in medicine, recent scientific investigations have corroborated their anti-inflammatory, anticancer, antibacterial, and neuroprotective characteristics. Their primary mechanisms of action encompass disruption of tumor-promoting pathways, modulation of inflammatory cytokines, and inhibition of 5-lipoxygenase (5-LO). Preclinical and clinical studies indicate that the treatment of chronic inflammatory illnesses such as rheumatoid arthritis, asthma, ulcerative colitis, and neurological diseases like Alzheimer's is effective. Additionally, their potential functions in regulating metabolic disorders such as obesity and diabetes are under scrutiny. Although recent pharmacokinetic advancements have improved the bioavailability of boswellic acids, further research is essential to optimize their therapeutic efficacy, evaluate long-term safety, and advance innovative delivery systems. This review provides a comprehensive analysis of the chemical composition, pharmacokinetics, mechanisms of action, and pharmacotherapeutic potential of boswellic acids, underscoring their growing importance in modern medicine.

Keywords:

Cite this article:
Jyoti Kumari, M.P. Chopra. Boswellic Acids: A Natural Compound with Expanding Therapeutic Horizons. Research Journal of Pharmacy and Technology. 2026;19(4):1875-4. doi: 10.52711/0974-360X.2026.00270

Cite(Electronic):
Jyoti Kumari, M.P. Chopra. Boswellic Acids: A Natural Compound with Expanding Therapeutic Horizons. Research Journal of Pharmacy and Technology. 2026;19(4):1875-4. doi: 10.52711/0974-360X.2026.00270 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-4-59

6. REFERENCES:
1. K.P. Meena, P. Choudhary, T. Karri, P. Samal, Preparation and Characterization of Rutin Loaded Microparticles for the treatment of Diabetes, Res. J. Pharm. Technol. 16 (2023) 4867–4874. https://doi.org/10.52711/0974-360X.2023.00789.
2. K. Luan, Y. Fan, Q. Yang, H. Yang, Z. Zhou, J. Huang, Z. She, T. Zou, H. Xiong, Z. Mei, Acetyl-11-keto-β-boswellic acid alleviates hepatic metabolic dysfunction by inhibiting MGLL activity, J. Lipid Res. 66 (2025) 100812. https://doi.org/https://doi.org/10.1016/j.jlr.2025.100812.
3. M.J. Aghababaei, M. Mashhadi Akbar Boojar, M. Mashhadi Akbar Boojar, Therapeutic Potentials of Boswellic Acid: An Updated Review for Researchers TT - پتانسیل‌های درمانی بوسولیک اسید: یک مرور به‌روز شده برای محققان, Jmciri 43 (2025) 6–17. https://doi.org/https://doi.org/10.22034/43.1.7.
4. F. Iram, S.A. Khan, A. Husain, Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review, Asian Pac. J. Trop. Biomed. 7 (2017) 513–523. https://doi.org/https://doi.org/10.1016/j.apjtb.2017.05.001.
5. G. Mannino, A. Occhipinti, M.E. Maffei, Quantitative Determination of 3-O-Acetyl-11-Keto-βBoswellic Acid (AKBA) and Other Boswellic Acids in Boswellia sacra Flueck (syn. B. carteri Birdw) and Boswellia serrata Roxb., Molecules 21 (2016). https://doi.org/10.3390/molecules21101329.
6. N. Solanki, S. Saini, S.K. Singh, K.R. Paudel, B.H. Goh, K. Dua, H. Dureja, Central composite designed boswellic acids loaded nanoparticles for enhanced cellular uptake in human lung cancer cell line A549, J. Drug Deliv. Sci. Technol. 105 (2025) 106591. https://doi.org/https://doi.org/10.1016/j.jddst.2024.106591.
7. S.S. Niphadkar, N.B. Bokhale, V.K. Rathod, Extraction of acetyl 11-keto-β-boswellic acid (AKBA) from Boswellia serrata plant oleo gum resin using novel three phase partitioning (TPP) technique, J. Appl. Res. Med. Aromat. Plants 7 (2017) 41–47. https://doi.org/https://doi.org/10.1016/j.jarmap.2017.04.007.
8. N.T.T. Le, V. Du Cao, T.N.Q. Nguyen, T.T.H. Le, T.T. Tran, T.T. Hoang Thi, Soy Lecithin-Derived Liposomal Delivery Systems: Surface Modification and Current Applications., Int. J. Mol. Sci. 20 (2019). https://doi.org/10.3390/ijms20194706.
9. J. Hüsch, J. Bohnet, G. Fricker, C. Skarke, C. Artaria, G. Appendino, M. Schubert-Zsilavecz, M. Abdel-Tawab, Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(®)) of Boswellia extract., Fitoterapia 84 (2013) 89–98. https://doi.org/10.1016/j.fitote.2012.10.002.
10. M. Schmiech, E. Abdel-Kahaar, J. Ulrich, M. Pfeiffer, A. Duweb, O. Zolk, T. Syrovets, T. Simmet, Single-dose comparative pharmacokinetic/pharmacodynamic study of a micellar formulation versus a native Boswellia serrata dry extract in healthy volunteers., Phytomedicine 132 (2024) 155863. https://doi.org/10.1016/j.phymed.2024.155863.
11. E.N. Ali, S.Z. Mansour, Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats., Chin. Med. 6 (2011) 36. https://doi.org/10.1186/1749-8546-6-36.
12. J.H. Lee, J.M. Berger, Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II, Genes (Basel). 10 (2019). https://doi.org/10.3390/genes10110859.
13. E. Ostrycharz, B. Hukowska-Szematowicz, New Insights into the Role of the Complement System in Human Viral Diseases, Biomolecules 12 (2022). https://doi.org/10.3390/biom12020226.
14. E.A. Ragab, M.F. Abd El-Wahab, A.S. Doghish, R.M. Salama, N. Eissa, S.F. Darwish, The journey of boswellic acids from synthesis to pharmacological activities., Naunyn. Schmiedebergs. Arch. Pharmacol. 397 (2024) 1477–1504. https://doi.org/10.1007/s00210-023-02725-w.
15. T. Sharma, S. Jana, Boswellic acids as natural anticancer medicine: Precious gift to humankind, J. Herb. Med. 20 (2020) 100313. https://doi.org/https://doi.org/10.1016/j.hermed.2019.100313.
16. F. Bie, G. Zhang, X. Yan, X. Ma, S. Zhan, Y. Qiu, J. Cao, Y. Ma, M. Ma, β-Boswellic Acid Suppresses Breast Precancerous Lesions via GLUT1 Targeting-Mediated Glycolysis Inhibition and AMPK Pathway Activation., Front. Oncol. 12 (2022) 896904. https://doi.org/10.3389/fonc.2022.896904.
17. S.A. Ahmed, A.F. Al-Shanon, A.Z. Al-Saffar, A. Tawang, J.R. Al-Obaidi, Antiproliferative and cell cycle arrest potentials of 3-O-acetyl-11-keto-β-boswellic acid against MCF-7 cells in vitro, Journal of Genetic Engineering and Biotechnology 21 (2023) 75. https://doi.org/https://doi.org/10.1186/s43141-023-00529-2.
18. N.K. Roy, D. Parama, K. Banik, D. Bordoloi, A.K. Devi, K.K. Thakur, G. Padmavathi, M. Shakibaei, L. Fan, G. Sethi, A.B. Kunnumakkara, An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases., Int. J. Mol. Sci. 20 (2019). https://doi.org/10.3390/ijms20174101.
19. M. Lv, X. Zhuang, Q. Zhang, Y. Cheng, D. Wu, X. Wang, T. Qiao, Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway, Cell Biol. Toxicol. 37 (2021) 209–228. https://doi.org/10.1007/s10565-020-09541-5.
20. M. Boța, L. Vlaia, A.-R. Jîjie, I. Marcovici, F. Crişan, C. Oancea, C.A. Dehelean, T. Mateescu, E.-A. Moacă, Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer., Pharmaceuticals (Basel) 17 (2024). https://doi.org/10.3390/ph17050598.
21. L. Jin, W. Yingchun, S. Zhujun, W. Yinan, W. Dongchen, Y. Hui, Y. Xi, Z. Wanzhou, Z. Buluan, W. Jinhua, 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function, Biomedicine and Pharmacotherapy 116 (2019) 108992. https://doi.org/https://doi.org/10.1016/j.biopha.2019.108992.
22. L. Ranjbaran, R. Masoudi, S.L. Abtahi, Anticancer Effects of AKBA on Glioblastoma Cancer Cells Through Modulating TWIST1 and FOXM1 Expression Levels, Iranian Journal of Science and Technology, Transactions A: Science 45 (2021) 437–442. https://doi.org/10.1007/s40995-020-01026-8.
23. K. Nagori, M. Pradhan, K. T. Nakhate, H. R. Badwaik, R. Deshmukh, A. Roy, R. Sharma, S. P. Srivastava, S. Chawla, V. Jain, M. Sharma, In silico Molecular Docking Analysis of some Terpenoids against 3CLpro of SARS-CoV-2, Res. J. Pharm. Technol. (2023) 4791–4798. https://doi.org/10.52711/0974-360x.2023.00777.
24. S.W. Fatima, S. Alam, S.K. Khare, Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors, Phytomedicine Plus 2 (2022) 100241. https://doi.org/https://doi.org/10.1016/j.phyplu.2022.100241.
25. H. Hussain, Can the golden nutraceutical frankincense combat COVID-19?, Future Postharvest and Food 1 (2024) 161–165. https://doi.org/https://doi.org/10.1002/fpf2.12002.
26. Y. Liu, L. Yang, H. Wang, Y. Xiong, Recent Advances in Antiviral Activities of Triterpenoids., Pharmaceuticals (Basel) 15 (2022). https://doi.org/10.3390/ph15101169.
27. H. Hussain, D. Wang, H.R. El-Seedi, L. Rashan, I. Ahmed, M. Abbas, N.Z. Mamadalieva, H.N. Sultani, M.I. Hussain, S.T.A. Shah, Therapeutic potential of boswellic acids: an update patent review (2016-2023)., Expert Opin. Ther. Pat. 34 (2024) 723–732. https://doi.org/10.1080/13543776.2024.2369626.
28. C.L.C. Almeida-da-Silva, N. Sivakumar, H. Asadi, A. Chang-Chien, M.W. Qoronfleh, D.M. Ojcius, M.M. Essa, Effects of Frankincense Compounds on Infection, Inflammation, and Oral Health, Molecules 27 (2022). https://doi.org/10.3390/molecules27134174.
29. S. Pérez-Piñero, J.C. Muñoz-Carrillo, D. Victoria-Montesinos, A.M. García-Muñoz, L. Andreu-Caravaca, M. Gómez, M. Schölzel, A.I. García-Guillén, F.J. López-Román, Efficacy of Boswellia serrata Extract and/or an Omega-3-Based Product for Improving Pain and Function in People Older Than 40 Years with Persistent Knee Pain: A Randomized Double-Blind Controlled Clinical Trial., Nutrients 15 (2023). https://doi.org/10.3390/nu15173848.
30. D. Banji, O.J.F. Banji, S. Rashida, S. Alshahrani, S.S. Alqahtani, Bioavailability, anti-inflammatory and anti-arthritic effect of Acetyl Keto Boswellic acid and its combination with methotrexate in an arthritic animal model., J. Ethnopharmacol. 292 (2022) 115200. https://doi.org/10.1016/j.jep.2022.115200.
31. P.R. Kiela, A.J. Midura, N. Kuscuoglu, S.D. Jolad, A.M. Sólyom, D.G. Besselsen, B.N. Timmermann, F.K. Ghishan, Effects of Boswellia serrata in mouse models of chemically induced colitis, American Journal of Physiology-Gastrointestinal and Liver Physiology 288 (2005) G798–G808. https://doi.org/10.1152/ajpgi.00433.2004.
32. A. Haroyan, V. Mukuchyan, N. Mkrtchyan, N. Minasyan, S. Gasparyan, A. Sargsyan, M. Narimanyan, A. Hovhannisyan, Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study., BMC Complement. Altern. Med. 18 (2018) 7. https://doi.org/10.1186/s12906-017-2062-z.
33. M. Pradhan, A. Alexander, Ajazuddin, Development and validation of a robust RP-HPLC method for analysis of calcipotriol in pharmaceutical dosage form, Res. J. Pharm. Technol. 12 (2019) 579–583. https://doi.org/10.5958/0974-360X.2019.00103.3.
34. M. Karimi, K. Vakili, P. Rashidian, S.-K. Razavi-Amoli, M. Akhbari, K. Kazemi, Effect of boswellia (Boswellia serrata L.) supplementation on glycemic markers and lipid profile in type 2 diabetic patients: a systematic review and meta-analysis, Frontiers in Clinical Diabetes and Healthcare 5 (2024). https://doi.org/10.3389/fcdhc.2024.1466408.
35. A. Khan, I. Khan, S.A. Halim, N.U. Rehman, N. Karim, W. Ahmad, M. Khan, R. Csuk, A. Al-Harrasi, Anti-diabetic potential of β-boswellic acid and 11-keto-β-boswellic acid: Mechanistic insights from computational and biochemical approaches, Biomedicine and Pharmacotherapy 147 (2022) 112669. https://doi.org/https://doi.org/10.1016/j.biopha.2022.112669.
36. H. Al-Matubsi, L. Rashan, W. Aburayyan, O. Al Hanbali, D. Abuarqoub, T. Efferth, Antidiabetic and antioxidant properties of Boswellia sacra oleo-gum in streptozotocin-induced diabetic rats., J. Ayurveda Integr. Med. 15 (2024) 101014. https://doi.org/10.1016/j.jaim.2024.101014.
37. S. Mehrzadi, B. Tavakolifar, H.F. Huseini, S.H. Mosavat, M. Heydari, The Effects of Boswellia serrata Gum Resin on the Blood Glucose and Lipid Profile of Diabetic Patients: A Double-Blind Randomized Placebo-Controlled Clinical Trial, J. Evid. Based. Integr. Med. 23 (2018) 2515690X18772728. https://doi.org/10.1177/2515690X18772728.
38. U. Siemoneit, L. Tausch, D. Poeckel, M. Paul, H. Northoff, A. Koeberle, J. Jauch, O. Werz, Defined Structure-Activity Relationships of Boswellic Acids Determine Modulation of Ca2+ Mobilization and Aggregation of Human Platelets by Boswellia serrata Extracts., Planta Med. 83 (2017) 1020–1027. https://doi.org/10.1055/s-0043-107884.
39. M.R. Singh, K. Yadav, N.D. Chaurasiya, D. Singh, Immune System and Mechanism of Immunomodulation, in: N.S. Sangwan, M.A. Farag, L.V. Modolo (Eds.), Plants and Phytomolecules for Immunomodulation: Recent Trends and Advances, Springer Nature Singapore, Singapore, 2022: pp. 1–31. https://doi.org/10.1007/978-981-16-8117-2_1.
40. D. Beghelli, G. Isani, P. Roncada, G. Andreani, O. Bistoni, M. Bertocchi, G. Lupidi, A. Alunno, Antioxidant and Ex Vivo Immune System Regulatory Properties of Boswellia serrata Extracts., Oxid. Med. Cell. Longev. 2017 (2017) 7468064. https://doi.org/10.1155/2017/7468064.
41. L. V Krepkova, A.N. Babenko, O.L. Saybel’, I.A. Lupanova, O.S. Kuzina, K.M. Job, C.M. Sherwin, E.Y. Enioutina, Valuable Hepatoprotective Plants - How Can We Optimize Waste Free Uses of Such Highly Versatile Resources?, Front. Pharmacol. 12 (2021) 738504. https://doi.org/10.3389/fphar.2021.738504.
42. H.M. Eltahir, M.A. Fawzy, E.M. Mohamed, M.A. Alrehany, A.M. Shehata, M.M. Abouzied, Antioxidant, anti-inflammatory and anti-fibrotic effects of Boswellia serrate gum resin in CCl(4)-induced hepatotoxicity., Exp. Ther. Med. 19 (2020) 1313–1321. https://doi.org/10.3892/etm.2019.8353.
43. S.A. Zaitone, B.M. Barakat, S.E. Bilasy, M.S. Fawzy, E.Z. Abdelaziz, N.E. Farag, Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure., Naunyn. Schmiedebergs. Arch. Pharmacol. 388 (2015) 587–600. https://doi.org/10.1007/s00210-015-1102-9.
44. M. Kumar, G. Singh, P. Bhardwaj, S.K. Dhatwalia, D.K. Dhawan, Understanding the role of 3-O-Acetyl-11-keto-β-boswellic acid in conditions of oxidative-stress mediated hepatic dysfunction during benzo(a)pyrene induced toxicity, Food and Chemical Toxicology 109 (2017) 871–878. https://doi.org/https://doi.org/10.1016/j.fct.2017.03.058.
45. N.M. Thabet, M.K. Abdel-Rafei, E.M. Moustafa, Boswellic acid protects against Bisphenol-A and gamma radiation induced hepatic steatosis and cardiac remodelling in rats: role of hepatic PPAR-α/P38 and cardiac Calcineurin-A/NFATc1/P38 pathways., Arch. Physiol. Biochem. 128 (2022) 767–785. https://doi.org/10.1080/13813455.2020.1727526.
46. Z. Liu, X. Liu, L. Sang, H. Liu, Q. Xu, Z. Liu, Boswellic acid attenuates asthma phenotypes by downregulation of GATA3 via pSTAT6 inhibition in a murine model of asthma., Int. J. Clin. Exp. Pathol. 8 (2015) 236–243.
47. C. Suther, L. Devon, L. Daddi, A. Matson, H. Panier, H. Yuan, K. Saar, S. Bokoliya, Y. Dorsett, D.A. Sela, A. Beigelman, L.B. Bacharier, M.D. Moore, Y. Zhou, Dietary Indian frankincense (Boswellia serrata) ameliorates murine allergic asthma through modulation of the gut microbiome, J. Funct. Foods 97 (2022) 105249. https://doi.org/https://doi.org/10.1016/j.jff.2022.105249.
48. Veintramuthusankar, Pushparajudayakumar, Rajanduraibabyroselin, Development of Mupirocin- Tinidazole solid- Lipid Nanoparticles Loaded Topical gel for the Management of Bacterial Wound Infections., Res. J. Pharm. Technol. 14 (2021) 2785–2790. https://doi.org/10.52711/0974-360X.2021.00491.
49. P. Jaroš, E. Timkina, J. Michailidu, D. Maršík, M. Kulišová, I. Kolouchová, K. Demnerová, Boswellic Acids as Effective Antibacterial Antibiofilm Agents., Molecules 27 (2022). https://doi.org/10.3390/molecules27123795.
50. N.G.M. Attallah, W.A. Negm, E. Elekhnawy, N. Altwaijry, E.I. Elmongy, T.A. El-Masry, E.A. Alturki, D.A. Yousef, M. Y Shoukheba, Antibacterial Activity of Boswellia sacra Flueck. Oleoresin Extract against Porphyromonas gingivalis Periodontal Pathogen., Antibiotics (Basel) 10 (2021). https://doi.org/10.3390/antibiotics10070859.
51. A. Alwashli, M. Al-sobarry, R. Alnamer, Y. Cherrah, K. Alaoui, Analgesic and Anti-inflammatory Activities of Boswellia elongata balf Methanolic Extracts, as Endemic Plants in Yemen, Journal of Biologically Active Products from Nature 2 (2012) 90–98. https://doi.org/10.1080/22311866.2012.10719114.
52. M. Bishnoi, C.S. Patil, A. Kumar, S.K. Kulkarni, Analgesic activity of acetyl-11-keto-beta-boswellic acid, a 5-lipoxygenase-enzyme inhibitor, Indian J. Pharmacol. 37 (2005). https://journals.lww.com/iphr/fulltext/2005/37040/analgesic_activity_of.11.aspx.
53. A. Al-Harrasi, L. Ali, J. Hussain, N.U. Rehman, Mehjabeen, M. Ahmed, A. Al-Rawahi, Analgesic effects of crude extracts and fractions of Omani frankincense obtained from traditional medicinal plant Boswellia sacra on animal models, Asian Pac. J. Trop. Med. 7 (2014) S485–S490. https://doi.org/https://doi.org/10.1016/S1995-7645(14)60279-0.
54. K. Nagori, M. Pradhan, K.T. Nakhate, Ethyl gallate ameliorates diabetes-induced Alzheimer’s disease-like phenotype in rats via activation of α7 nicotinic receptors and mitigation of oxidative stress, Biochem. Biophys. Res. Commun. 737 (2024) 150925. https://doi.org/https://doi.org/10.1016/j.bbrc.2024.150925.
55. K. Nagori, K.T. Nakhate, K. Yadav, Ajazuddin, M. Pradhan, Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights, Future Pharmacology 3 (2023) 877–907. https://doi.org/10.3390/futurepharmacol3040053.
56. S. Beheshti, R. Aghaie, Therapeutic effect of frankincense in a rat model of Alzheimer’s disease., Avicenna J. Phytomed. 6 (2016) 468–475.
57. T.M. Mohamed, M.A.M. Youssef, A.A. Bakry, M.M. El-Keiy, Alzheimer’s disease improved through the activity of mitochondrial chain complexes and their gene expression in rats by boswellic acid, Metab. Brain Dis. 36 (2021) 255–264. https://doi.org/10.1007/s11011-020-00639-7.
58. X. MIAO, L. ZHENG, Z. ZHAO, S. SU, Y. ZHU, J. GUO, E. SHANG, D. QIAN, J. DUAN, Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on Neuroinflammation by LPS-Induced BV2 Cells Combined with Network Pharmacology, Molecules 24 (2019). https://doi.org/10.3390/molecules24213946.
59. A.S. Sayed, N.S.E.D. El Sayed, Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways., J. Mol. Neurosci. 59 (2016) 58–67. https://doi.org/10.1007/s12031-016-0734-7.
60. E.A. Mohamed, H.I. Ahmed, H.S. Zaky, A.M. Badr, Boswellic acids ameliorate neurodegeneration induced by AlCl(3): the implication of Wnt/β-catenin pathway., Environ. Sci. Pollut. Res. Int. 29 (2022) 76135–76143. https://doi.org/10.1007/s11356-022-20611-5.
61. T. Yang, X. Lin, H. Li, X. Zhou, F. Fan, J. Yang, Y. Luo, X. Liu, Acetyl-11-Keto-Beta Boswellic Acid (AKBA) Protects Lens Epithelial Cells Against H(2)O(2)-Induced Oxidative Injury and Attenuates Cataract Progression by Activating Keap1/Nrf2/HO-1 Signaling., Front. Pharmacol. 13 (2022) 927871. https://doi.org/10.3389/fphar.2022.927871.
62. C. IOVINO, V. Di Iorio, A.A. Rosolia, I. Schiavetti, M. Lanza, F. Testa, F. Simonelli, Curcuma Longa and Boswellia Serrata Oral Administration in patients with Treatment-Naïve Diabetic Macular Edema, Invest. Ophthalmol. Vis. Sci. 64 (2023) 2686.
63. M. Lulli, M. Cammalleri, I. Fornaciari, G. Casini, M. Dal Monte, Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy, Exp. Eye Res. 135 (2015) 67–80. https://doi.org/https://doi.org/10.1016/j.exer.2015.04.011.
64. Y. Sun, D. Liu, R. Xi, X. Wang, Y. Wang, J. Hou, B. Zhang, C. Wang, K. Liu, X. Ma, Microbial transformation of acetyl-11-keto-β-boswellic acid and their inhibitory activity on LPS-induced NO production., Bioorg. Med. Chem. Lett. 23 (2013) 1338–1342. https://doi.org/10.1016/j.bmcl.2012.12.086.
65. Y. Wang, Y. Sun, C. Wang, X. Huo, P. Liu, C. Wang, B. Zhang, L. Zhan, H. Zhang, S. Deng, Y. Zhao, X. Ma, Biotransformation of 11-keto-β-boswellic acid by Cunninghamella blakesleana., Phytochemistry 96 (2013) 330–336. https://doi.org/10.1016/j.phytochem.2013.07.018.
66. B. Büchele, W. Zugmaier, A. Estrada, F. Genze, T. Syrovets, C. Paetz, B. Schneider, T. Simmet, Characterization of 3alpha-acetyl-11-keto-alpha-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo., Planta Med. 72 (2006) 1285–1289. https://doi.org/10.1055/s-2006-951680.
67. S.A.F. Morad, M. Schmid, B. Büchele, H.-U. Siehl, M. El Gafaary, O. Lunov, T. Syrovets, T. Simmet, A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells., Mol. Pharmacol. 83 (2013) 531–541. https://doi.org/10.1124/mol.112.081349.
68. S. Priya, G. Singhvi, Insights into the anti-inflammatory and anti-arthritic potential of 3-Acetyl-11-keto-β-Boswellic Acid as a therapeutic approach in Rheumatoid Arthritis, Expert Opin. Investig. Drugs 32 (2023) 867–871. https://doi.org/10.1080/13543784.2023.2269838.
69. P. Ravanan, S.K. Singh, G.S. Rao, P. Kondaiah, Growth inhibitory, apoptotic and anti-inflammatory activities displayed by a novel modified triterpenoid, cyano enone of methyl boswellates., J. Biosci. 36 (2011) 297–307. https://doi.org/10.1007/s12038-011-9056-7.
70. N.K. Roy, A. Deka, D. Bordoloi, S. Mishra, A.P. Kumar, G. Sethi, A.B. Kunnumakkara, The potential role of boswellic acids in cancer prevention and treatment, Cancer Lett. 377 (2016) 74–86. https://doi.org/https://doi.org/10.1016/j.canlet.2016.04.017.